AU2001293891A1 - New combination for the treatment of asthma - Google Patents
New combination for the treatment of asthmaInfo
- Publication number
- AU2001293891A1 AU2001293891A1 AU2001293891A AU9389101A AU2001293891A1 AU 2001293891 A1 AU2001293891 A1 AU 2001293891A1 AU 2001293891 A AU2001293891 A AU 2001293891A AU 9389101 A AU9389101 A AU 9389101A AU 2001293891 A1 AU2001293891 A1 AU 2001293891A1
- Authority
- AU
- Australia
- Prior art keywords
- asthma
- treatment
- new combination
- new
- combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Otolaryngology (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20002177 | 2000-10-02 | ||
FI20002177A FI20002177A0 (fi) | 2000-10-02 | 2000-10-02 | Uusi yhdistelmä astman hoitoon |
PCT/FI2001/000854 WO2002028368A1 (fr) | 2000-10-02 | 2001-10-01 | Nouveau medicament combine pour le traitement de l"asthme |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001293891A1 true AU2001293891A1 (en) | 2002-04-15 |
Family
ID=8559216
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001293891A Abandoned AU2001293891A1 (en) | 2000-10-02 | 2001-10-01 | New combination for the treatment of asthma |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2001293891A1 (fr) |
FI (1) | FI20002177A0 (fr) |
WO (1) | WO2002028368A1 (fr) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030055026A1 (en) | 2001-04-17 | 2003-03-20 | Dey L.P. | Formoterol/steroid bronchodilating compositions and methods of use thereof |
JP4755495B2 (ja) | 2002-12-12 | 2011-08-24 | ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング | 組合せ医薬品 |
GB0312148D0 (en) | 2003-05-28 | 2003-07-02 | Aventis Pharma Ltd | Stabilized pharmaceutical products |
SE527069C2 (sv) | 2003-06-19 | 2005-12-13 | Mederio Ag | Förfarande och anordning för administrering av läkemedelspulver |
GB0315889D0 (en) | 2003-07-08 | 2003-08-13 | Aventis Pharma Ltd | Stable pharmaceutical products |
TWI359675B (en) | 2003-07-10 | 2012-03-11 | Dey L P | Bronchodilating β-agonist compositions |
PT1670482E (pt) | 2003-09-16 | 2014-03-12 | Takeda Gmbh | Utilização de ciclesonida para o tratamento de doenças respiratórias |
JP5156397B2 (ja) | 2005-02-10 | 2013-03-06 | グラクソ グループ リミテッド | 予備分級技術を用いて乳糖を製造する方法及びその乳糖から形成させた医薬製剤 |
EP1982709A1 (fr) | 2007-04-19 | 2008-10-22 | CHIESI FARMACEUTICI S.p.A. | Utilisation d'une composition comportant du formotérol et du dipropionate de béclométhasone pour la prévention ou le traitement d'une condition aiguë de l'asthme |
EP2022798A1 (fr) | 2007-08-09 | 2009-02-11 | CHIESI FARMACEUTICI S.p.A. | Peptides synthétiques de surfactant pulmonaire |
EP2080508A1 (fr) * | 2008-01-15 | 2009-07-22 | CHIESI FARMACEUTICI S.p.A. | Formulation de poudre sèche comprenant un médicament anticholinérgique |
PL2821061T3 (pl) * | 2013-07-01 | 2018-05-30 | Arven Ilac Sanayi Ve Ticaret A.S. | Nowe preparaty do inhalacji |
US20190076607A1 (en) | 2017-09-13 | 2019-03-14 | Lupin Atlantis Holdings Sa | Inhaler and mesh for an inhaler |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL104068A (en) * | 1991-12-12 | 1998-10-30 | Glaxo Group Ltd | Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant |
SE9700135D0 (sv) * | 1997-01-20 | 1997-01-20 | Astra Ab | New formulation |
EP0969816B1 (fr) * | 1997-03-20 | 2004-12-15 | Schering Corporation | Preparation d'agglomerats de poudre |
BR0015884A (pt) * | 2000-05-22 | 2003-07-08 | Chiesi Farma Spa | Formulações de soluções farmacêuticas estáveis para inaladores de dose medida pressurizados |
-
2000
- 2000-10-02 FI FI20002177A patent/FI20002177A0/fi unknown
-
2001
- 2001-10-01 WO PCT/FI2001/000854 patent/WO2002028368A1/fr active Application Filing
- 2001-10-01 AU AU2001293891A patent/AU2001293891A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2002028368A1 (fr) | 2002-04-11 |
FI20002177A0 (fi) | 2000-10-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002223827A1 (en) | Well treatment | |
AU2002348135A1 (en) | Methods for the treatment of addiction | |
AU2002224927A1 (en) | Use of substituted imidazoazines, novel imidazoazines, methods for the production thereof, and agents containing these compounds | |
AU2002223028A1 (en) | Inhaler | |
AU2002359163A1 (en) | New use | |
AU2001272852A1 (en) | Composition for the treatment of migraine | |
AU2002219229A1 (en) | Means for the diagnosis and therapy of CTCL | |
AU2002210385A1 (en) | Furazanyl-triazole derivates for the treatment of diseases | |
AU2001285747A1 (en) | Method for the treatment of tobacco | |
AU2001293891A1 (en) | New combination for the treatment of asthma | |
AU2001260834A1 (en) | The treatment of herpes | |
AU2001249262A1 (en) | Therapeutic compounds for the treatment of asthma and allergy, and methods of use thereof | |
AU2002335667A1 (en) | Modified reoviral therapy | |
AU2001285156A1 (en) | Combination therapy for the treatment of migraine | |
AU2002258798A1 (en) | Methods for the treatment of hepatic disorders | |
AU2002329441A1 (en) | Process for the preparation of 3 - isochromanone | |
AU2002343100A1 (en) | The use of metal-chelating adsorbents | |
AU2001261324A1 (en) | Psoriasis treatment | |
AU2003269257A1 (en) | Use of cap-1 for the therapy of asthma | |
AU2002358085A1 (en) | Process for the preparation of 4-methyl-7-aminoquinolones | |
AU3071899A (en) | Use of pkc-inhibitors for the manufacture of a medicament for the treatment of asthma | |
AU2002256967A1 (en) | Treating or reducing the risk of cardiovascular disease | |
AU2000272704A1 (en) | Use of compounds for the treatment of obesity | |
AU2001253560A1 (en) | Methods of treatment | |
AU2001292897A1 (en) | Novel therapy |